Impact of components and methods of measurement of blood pressure on damage of target organs and cardiovascular complications in arterial hypertension;Impacto de los componentes y sistemas de medición de la presión arterial sobre la lesíon de órgano diana y las complicaciones cardiovasculares en la hipertensión arterial

Medicina Clinica

Volumn 119, Issue 4, 2002, Pages 125-129

  de la Sierra, Alejandro ^a   Bové, Albert ^a   Sierra, Cristina ^a   Bragulat, Ernesto ^a   Gómez Angelats, Elisenda ^a   Antonio, María Teresa ^a   Larrousse, María ^a   Coca, Antonio ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Ambulatory blood pressure monitoring; Cardiovascular disease; Hypertension; Target organ damage

Indexed keywords

CREATININE; PROTEIN;

ADULT; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; ELECTROCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HUMAN TISSUE; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; ORGAN INJURY; PROTEIN URINE LEVEL; PROTEINURIA; PULSE PRESSURE; RETROSPECTIVE STUDY; STANDARDIZATION; STROKE; SYSTOLIC BLOOD PRESSURE; TARGET ORGAN; TIME;

EID: 0037193728     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(02)73340-x     Document Type: Article

References (38)

1. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996;275:1571-6.
2. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 1993;153:598-615.
3. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001;345:1291-7.
4. Van den Hoogen PCW, Feskens EJM, Nagelkerke NJD, Menotti A, Nissinen A, Kromhout D, for the Seven Countries Study Research Group. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. N Engl J Med 2000;342:1-8.
5. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, et al, for the WHO MONICA Project. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000;355:675-87.
6. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.
7. Blood Pressure Lowering Treatment Trialists' Collaboration. Effect of ACE inhibitors, calcium antagonists, and other blood pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000;355:1955-64.
8. Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000;355:865-72.
9. Palatini P, Mormino P, Canali C, Santonastaso M, De Venuto G, Zanata G, et al. Factors affecting ambulatory blood pressure reproducibility. Results of the HARVEST trial. Hypertension 1994;23:211-6.
10. Coats AJS, Radaelli A, Clark SJ, Conway J, Sleight P. The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension. J Hypertens 1992;10:385-91.
11. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressure. JAMA 1983;249:2792-8.
12. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994;24:793-801.
13. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, De Leeuw PW, et al, for the Systolic Hypertension in, Europe Trial Investigators. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999;282:539-46.
14. Fagard R, Staessen J, Thijs L, Amery A. Multiple standardized clinic blood pressures may predict left ventricular mass as well as ambulatory monitoring. Am J Hypertens 1995;8:533-40.
15. Mancia G, Zanchetti A, Agebiti-Rosei E, Benemio G, De Cesaris R, Fogari R, et al, for the SAMPLE Study Group. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Circulation 1997;95:1464-70.
16. Palatini P, Graniero GR, Mormino P, Mattarei M, Sanzuol F, Cignacco GB, et al, on behalf of the HARVEST Study Group. Prevalence and clinical correlates of microalbuminuria in stage I hypertension. Results form the Hypertension and Ambulatory Recording Venetian Study. Am J Hypertens 1996;9:334-41.
17. Clausen P, Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Ambulatory blood pressure and urinary albumin excretion in clinically healthy subjects. Hypertension 1998;32:71-7.
18. The British Hypertension Society. Blood pressure measurement. London: BMJ Books, 1998.
19. O'Brien E, Atkins N, Mee F, O'Malley K. Evaluation of the SpaceLabs 90202 according to the AAMI standard and BHS criteria. J Hum Hypertens 1991;5:223-6.
20. O'Brien E, Mee F, Atkins N, O'Malley K. Accuracy of the SpaceLabs 90207 determined by to the British Hypertension Society Protocol. J Hypertens 1991;9(Suppl 5):25-31.
21. Baumgart P, Kamp J. Accuracy of the Space-Labs Medical 90217 ambulatory blood pressure monitor. Blood Press Monit 1998;3:303-7.
22. Palma JL, Isasa MD. Evaluación clínica del ACP-2200: un nuevo equipo oscilométrico para el registro ambulatorio continuo de la presión arterial. Hipertensión 1990;7:250-6.
23. Casale PIN, Devereux RB, Kligfield P, Eisenberg RR, Miller DH, Chaudhary BS, et al. Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol 1985;6:572-80.
24. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949;37:161-86.
25. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
26. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton JD, et al. Blood pressure, stroke, and coronary heart disease. Part I. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
27. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease: the Framingham study. Am J Cardiol 1971;27:335-46.
28. Kannel WB, Wolf PA, McGee DL. Systolic blood pressure, arterial rigidity and risk of stroke: the Framingham study. JAMA 1981;245:1225-9.
29. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
30. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997;350:757-64.
31. Franklin SS, Gustin W, Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997;96:308-15.
32. Franklin SS, Khan SA, Wong ND, Larson MG, Levi D. Is pulse pressure useful in predicting risk for coronary Herat disease? The Framingham Heart Study. Circulation 1999;100:354-60.
33. Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JL, Ducimetière P, et al. Pulse pressure. A predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997;30:1410-5.
34. Mancia G, Parati G. Ambulatory blood pressure monitoring and organ damage. Hypertension 2000;36:894-900.
35. Omboni S, Parati G, Palatini P, Vanasia A, Muiesan ML, Cuspidi C, et al. Reproducibility and clinical value of nocturnal hypotension: prospective evidence for the SAMPLE study. J Hypertens 1998;16:733-8.
36. Sierra C, De la Sierra A, Mercader J, Gómez-Angelats E, Urbano-Márquez A, Coca A. Silent cerebral white matter lesions in middle-aged essential hypertensive patients. J Hypertens 2002;20:519-24.
37. Villar C, García-Puig J, Martínez MA, Aguirre A, Sánchez M, Nevado A. Determinación de la presión arterial por médico o enfermera: relación con la presión ambulatoria y la masa del ventrículo izquierdo. Med Clin (Barc) 1999;113:770-4.
38. Parati G, Ulian L, Sampieri P, Palatini P, Villani A, Vanasia G, et al. Attenuation of the «whitecoat» effect by antihypertensive treatment and regression of target organ damage. Hypertension